Patents by Inventor Yoong-Sik Park

Yoong-Sik Park has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITIONS COMPRISING A DIAMINOPYRIMIDINE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND PROCESSES FOR PREPARING THE SAME
    Publication number: 20230255967
    Abstract: The present invention provides a pharmaceutical composition comprising (S)—N-(1-(2-((4-amino-3-nitrophenyl)amino)-6-propylpyrimidin-4-yl)pyrrolidin-3-yl)acetamide or a pharmaceutically acceptable salt thereof having an activity as a 5-HT4 receptor agonist and an acidifying agent; and a process for preparing the same.
    Type: Application
    Filed: July 1, 2021
    Publication date: August 17, 2023
    Applicant: YUHAN CORPORATION
    Inventors: Dong-Min Park, Su-Hyeon Kim, Eun-Pa Cheon, Tae-Lin Ha, Jun-Mo Yang, Yoong-Sik Park
  • PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION COMPRISING AMINOPYRIMIDINE DERIVATIVE OR ITS SALT
    Publication number: 20210322428
    Abstract: The present disclosure provides a pharmaceutical composition for oral administration comprising: N-(5-(4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pirimidine-2-ylamino)-4-methoxy-2-morpholinophenyl)acrylamide (Lazertinib) or its pharmaceutically acceptable salt as an active ingredient; and a combination of microcrystalline cellulose and mannitol as a diluent.
    Type: Application
    Filed: October 17, 2019
    Publication date: October 21, 2021
    Inventors: Seongkyu KIM, Deokkyu LEE, Soo-Won KIM, Jun-Mo YANG, Yoong-Sik PARK
  • SUSTAINED RELEASE TABLET COMPRISING PREGABALIN THROUGH TWO-PHASE RELEASE-CONTROLLING SYSTEM
    Publication number: 20180147150
    Abstract: Provided is a sustained release tablet having two-phase release-controlling system, which consists of a first release-controlling phase including pregabalin or its salt and hydroxypropyl methylcellulose; and a second release-controlling phase including polyethylene oxide as a swelling polymer, the first release-controlling phase being homogeneously dispersed in the second release-controlling phase.
    Type: Application
    Filed: January 29, 2018
    Publication date: May 31, 2018
    Applicant: YUHAN CORPORATION
    Inventors: Jeong-Hoon WOO, Woon-Sook NA, Yang-Soo JEONG, Chang-Keun HYUN, Yoong-Sik PARK
  • SUSTAINED RELEASE TABLET COMPRISING PREGABALIN THROUGH TWO-PHASE RELEASE-CONTROLLING SYSTEM
    Publication number: 20140161880
    Abstract: Provided is a sustained release tablet having two-phase release-controlling system, which consists of a first release-controlling phase comprising pregabalin or its salt and hydroxypropyl methylcellulose; and a second release-controlling phase comprising polyethylene oxide as a swelling polymer, the first release-controlling phase being homogeneously dispersed in the second release-controlling phase.
    Type: Application
    Filed: July 20, 2012
    Publication date: June 12, 2014
    Applicant: YUHAN CORPORATION
    Inventors: Jeong-Hoon Woo, Woon-Sook Na, Yang-Soo Jeong, Chang-Keun Hyun, Yoong-Sik Park